House approves reforms to pain‑management clinic licensure and oversight

Tennessee House of Representatives · April 8, 2026

Loading...

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Lawmakers passed legislation authorizing the Department of Health to identify high‑risk opioid prescribers, conduct chart reviews and investigations, and change medical‑director on‑site time calculations; sponsors said the changes accommodate specialist shortages while opponents asked about oversight details.

Chairman Kumar (sponsor) explained that the bill (substituted to Senate Bill 2279) reforms pain management clinic licensure and gives the Tennessee Department of Health authority to identify high‑risk opioid prescribers and conduct chart reviews and investigations. Kumar said criteria for identifying high‑risk prescribers would be published online and that the law reforms clinic management procedures.

Representative Powell asked whether the bill addresses predatory pain clinics that recruit accident victims; the sponsor said it does not directly regulate outreach practices but focuses on licensure and monitoring. Representative Barrett questioned a provision that reduces the time a medical director is required to be on‑site from 20% of weekly operating hours to 20% of quarterly operating hours; Kumar said the change reflects a shortage of specialists and provides additional leeway while assuring remote availability: "Coverage will be available at all times. And if the person is not on‑site, then they're immediately available by phone," Kumar said.

Members adopted the committee amendments and the House voted to pass the measure on third and final consideration; the speaker declared the bill passed after the clerk confirmed it had received a constitutional majority.

The bill directs the Department of Health to publish criteria for identifying high‑risk prescribers and allows chart reviews and investigations. The transcript records questions about whether the reforms address certain clinic outreach practices and about who will provide on‑site oversight if medical directors are less frequently present; sponsors said coverage and remote availability are intended to address those concerns.